Director & Chief Executive Officer
Director & Chief Executive Officer at Kymera Therapeutics, Inc., filing insider transactions between 2026-07-07 and 2026-10-01.
| SEC ↗ |
| 2026-10-01 | KYMR | Sale | 8,230 | $115.40 | $950K | SEC ↗ |
| 2026-10-01 | KYMR | Sale | 5,506 | $112.42 | $619K | SEC ↗ |
| 2026-10-01 | KYMR | Sale | 7,601 | $114.43 | $870K | SEC ↗ |
| 2026-07-07 | KYMR | Sale | 50.0K | $119.00 | $6.0M | SEC ↗ |